{"id":"W4399722033","doi":"10.1016/j.ejca.2024.114183","title":"Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Janssen Pharmaceuticals; AstraZeneca; Pfizer; Amgen; Astellas Pharma; Abbott Laboratories","keywords":"Abiraterone acetate; Prednisone; Medicine; Prostate cancer; Oncology; Covariate; Internal medicine; Placebo; Cancer; Statistics; Androgen deprivation therapy; Mathematics; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002924033,0.0001776735,0.0005415297,0.0002482075,0.00002257371,0.00004033691,0.0001761797,0.00001388179,0.00002070475],"category_scores_gemma":[0.00005705321,0.00007951022,0.00004629737,0.000478884,0.0001288658,0.0001485273,0.00002331139,0.0004598973,5.852621e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000263957,"about_ca_system_score_gemma":0.0004371693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001706395,"about_ca_topic_score_gemma":0.001448617,"domain_scores_codex":[0.9974251,0.0005632348,0.001000589,0.0002130214,0.0005377614,0.0002602451],"domain_scores_gemma":[0.9988848,0.0002105957,0.0003579319,0.000151966,0.0003383499,0.00005633008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02769841,0.00433084,0.8638662,0.0003686192,0.0003752418,0.0007200918,0.01043143,0.0007139029,0.00004737981,0.000007649033,0.00009268836,0.09134756],"study_design_scores_gemma":[0.05407649,0.009967481,0.9311367,0.001802758,0.0002281569,0.000005252074,0.001309375,0.0009374221,0.00005968908,0.000009451096,0.0003711978,0.000095977],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908221,0.004493664,0.00002988563,0.001830779,0.0001643917,0.002523564,0.0001090568,0.000003300002,0.00002319301],"genre_scores_gemma":[0.997285,0.002060791,0.00009253652,0.0001249084,0.00007533307,0.0001673515,0.00002766571,0.00003145988,0.0001349535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09125158,"threshold_uncertainty_score":0.3242332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04673604915791438,"score_gpt":0.3859914848494938,"score_spread":0.3392554356915795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}